4 Ways WCCT Global, an Altasciences Company, Can Help Your Company Avoid Delays and Hidden Costs in Phase 1 Clinical Trials

4 Ways WCCT Global, an Altasciences Company, Can
Help Your Company Avoid Delays and Hidden Costs

in Phase 1 Clinical Trials

4 Ways WCCT Global, an Altasciences Company, Can Help
Your Company Avoid Delays and Hidden Costs in Phase 1

Clinical Trials

When your company decides to start first in human clinical trials, it may be
advantageous to partner with a contract research organization (CRO) such as WCCT
Global, an Altasciences company. By sponsoring a Phase 1 clinical trial through a CRO,
you can utilize the experience and expertise of the organization, helping you avoid
delays and hidden costs that could negatively affect the study. Here are some of the
ways that WCCT can help optimize your Phase 1 clinical trial.

Utilizing Trained Staff
If your company lacks experience with medical writing or navigating regulations,
WCCT’s staff can help. Trained staff members can handle these tasks and perform
other aspects of research, including data management, project management,
biostatistics, and clinical monitoring. Utilizing WCCT’s experienced staff for these tasks
means a shorter start-up time for the trial, streamlining the study as early as possible in
the development stage and avoiding later delays.
Creating, Reviewing, and Implementing Recruitment Strategies

Recruitment strategies are critical for a Phase 1 clinical trial and must be tailored to
your specific study for best results. From age to gender to ethnicity, the inclusion and
exclusion criteria must be reviewed in detail when creating your study protocol to
ensure smooth recruitment and accurate data. For example, if your company plans to
release the drug in Asia, WCCT can help perform Ethnobridging studies. Using
Ethnobriding as a strategy to collect data on specific ethnicities can also alleviate the
need to repeat the Phase 1 clinical trial process in Asia, likely reducing the cost and
length of clinical development. WCCT staff can also assist with creating and marketing
an attractive recruitment structure for a successful clinical trial.

Ethnobridging Trial Expertise and an Extensive Participant Database

WCCT is an industry leader in conducting Ethnobridging trials. The CRO has conducted
more than 200 Ethnobridging studies since 2004 and is credited with conducting the
largest Ethnobridging study ever performed. As such, WCCT offers an extensive
participant database with more than 9,000 potential Asian participants. An average of
750 Asian participants are recruited yearly. Using their existing database can expedite
early clinical development phases because your company has a pool of participants to
pull from who are likely good candidates for participation.

Phase 1 Trial Units and Other Resources

Perhaps most importantly, your company will need somewhere to perform its Phase 1
clinical trial. WCCT offers partners the use of Phase 1 clinical trial units at its 80,000-
square-foot facility in Cypress, CA. The facility features 180 beds for overnight studies
and includes multiple on-site laboratories with various capabilities. An on-site USP-797
certified room for sterile drug preparation is also available. If WCCT does not already
offer the required resources for your trial, the CRO has a certified list of preferred
providers to fulfill your needs.

Utilize WCCT’s experience and expertise to sponsor a trial at
https://sponsor.wcct.com/

Original Source: https://bit.ly/3gwlSSi